 | • レポートコード：GIR-105X04851 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、シクロペントレートのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。シクロペントレートの種類別市場規模（特許、ジェネリック）、用途別市場規模（散瞳薬、ムスカリン受容体拮抗薬）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・シクロペントレートの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Alcon、Novartis、Laboratório Edol、Cadila Healthcare、FDC、Dr. Gerhard Mann、Abdi Ibrahim、Laboratorios Sophia、Bausch and Lomb、Santen、Riemser Arzneimittel、Teva、Akorn ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：特許、ジェネリック ・用途別分析2016年-2026年：散瞳薬、ムスカリン受容体拮抗薬 ・シクロペントレートの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・シクロペントレートのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・シクロペントレートのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・シクロペントレートの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・シクロペントレートの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Cyclopentolate market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Cyclopentolate size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Cyclopentolate market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Cyclopentolate market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Patent
Generic
Market segment by Application can be divided into
Mydriatic Agent
Muscarinic Receptor Antagonist
The key market players for global Cyclopentolate market are listed below:
Alcon
Novartis
Laboratório Edol
Cadila Healthcare
FDC
Dr. Gerhard Mann
Abdi Ibrahim
Laboratorios Sophia
Bausch and Lomb
Santen
Riemser Arzneimittel
Teva
Akorn
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Cyclopentolate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cyclopentolate, with price, sales, revenue and global market share of Cyclopentolate in 2018 and 2019.
Chapter 3, the Cyclopentolate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cyclopentolate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Cyclopentolate market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Cyclopentolate sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Cyclopentolate Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cyclopentolate Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Patent
1.2.3 Generic
1.3 Market Analysis by Application
1.3.1 Overview: Global Cyclopentolate Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Mydriatic Agent
1.3.3 Muscarinic Receptor Antagonist
1.4 Global Cyclopentolate Market Size & Forecast
1.4.1 Global Cyclopentolate Sales in Value (2016-2026))
1.4.2 Global Cyclopentolate Sales in Volume (2016-2026)
1.4.3 Global Cyclopentolate Price by Type (2016-2026) & (US$/Unit)
1.5 Global Cyclopentolate Production Capacity Analysis
1.5.1 Global Cyclopentolate Total Production Capacity (2016-2026)
1.5.2 Global Cyclopentolate Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Cyclopentolate Market Drivers
1.6.2 Cyclopentolate Market Restraints
1.6.3 Cyclopentolate Trends Analysis
2 Manufacturers Profiles
2.1 Alcon
2.1.1 Alcon Details
2.1.2 Alcon Major Business
2.1.3 Alcon Cyclopentolate Product and Services
2.1.4 Alcon Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Cyclopentolate Product and Services
2.2.4 Novartis Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Laboratório Edol
2.3.1 Laboratório Edol Details
2.3.2 Laboratório Edol Major Business
2.3.3 Laboratório Edol Cyclopentolate Product and Services
2.3.4 Laboratório Edol Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Cadila Healthcare
2.4.1 Cadila Healthcare Details
2.4.2 Cadila Healthcare Major Business
2.4.3 Cadila Healthcare Cyclopentolate Product and Services
2.4.4 Cadila Healthcare Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 FDC
2.5.1 FDC Details
2.5.2 FDC Major Business
2.5.3 FDC Cyclopentolate Product and Services
2.5.4 FDC Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Dr. Gerhard Mann
2.6.1 Dr. Gerhard Mann Details
2.6.2 Dr. Gerhard Mann Major Business
2.6.3 Dr. Gerhard Mann Cyclopentolate Product and Services
2.6.4 Dr. Gerhard Mann Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Abdi Ibrahim
2.7.1 Abdi Ibrahim Details
2.7.2 Abdi Ibrahim Major Business
2.7.3 Abdi Ibrahim Cyclopentolate Product and Services
2.7.4 Abdi Ibrahim Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Laboratorios Sophia
2.8.1 Laboratorios Sophia Details
2.8.2 Laboratorios Sophia Major Business
2.8.3 Laboratorios Sophia Cyclopentolate Product and Services
2.8.4 Laboratorios Sophia Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Bausch and Lomb
2.9.1 Bausch and Lomb Details
2.9.2 Bausch and Lomb Major Business
2.9.3 Bausch and Lomb Cyclopentolate Product and Services
2.9.4 Bausch and Lomb Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Santen
2.10.1 Santen Details
2.10.2 Santen Major Business
2.10.3 Santen Cyclopentolate Product and Services
2.10.4 Santen Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Riemser Arzneimittel
2.11.1 Riemser Arzneimittel Details
2.11.2 Riemser Arzneimittel Major Business
2.11.3 Riemser Arzneimittel Cyclopentolate Product and Services
2.11.4 Riemser Arzneimittel Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Cyclopentolate Product and Services
2.12.4 Teva Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Akorn
2.13.1 Akorn Details
2.13.2 Akorn Major Business
2.13.3 Akorn Cyclopentolate Product and Services
2.13.4 Akorn Cyclopentolate Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Cyclopentolate Sales by Manufacturer
3.1 Global Cyclopentolate Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Cyclopentolate Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Cyclopentolate
3.4 Market Concentration Rate
3.4.1 Top 3 Cyclopentolate Manufacturer Market Share
3.4.2 Top 6 Cyclopentolate Manufacturer Market Share
3.5 Global Cyclopentolate Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Cyclopentolate Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Cyclopentolate Market Size by Region
4.1.1 Global Cyclopentolate Sales in Volume by Region (2016-2026)
4.1.2 Global Cyclopentolate Revenue by Region (2016-2026)
4.2 North America Cyclopentolate Revenue (2016-2026)
4.3 Europe Cyclopentolate Revenue (2016-2026)
4.4 Asia-Pacific Cyclopentolate Revenue (2016-2026)
4.5 South America Cyclopentolate Revenue (2016-2026)
4.6 Middle East and Africa Cyclopentolate Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Cyclopentolate Sales in Volume by Type (2016-2026)
5.2 Global Cyclopentolate Revenue by Type (2016-2026)
5.3 Global Cyclopentolate Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Cyclopentolate Sales in Volume by Application (2016-2026)
6.2 Global Cyclopentolate Revenue by Application (2016-2026)
6.3 Global Cyclopentolate Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Cyclopentolate Sales by Type (2016-2026)
7.2 North America Cyclopentolate Sales by Application (2016-2026)
7.3 North America Cyclopentolate Market Size by Country
7.3.1 North America Cyclopentolate Sales in Volume by Country (2016-2026)
7.3.2 North America Cyclopentolate Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Cyclopentolate Sales by Type (2016-2026)
8.2 Europe Cyclopentolate Sales by Application (2016-2026)
8.3 Europe Cyclopentolate Market Size by Country
8.3.1 Europe Cyclopentolate Sales in Volume by Country (2016-2026)
8.3.2 Europe Cyclopentolate Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Cyclopentolate Sales by Type (2016-2026)
9.2 Asia-Pacific Cyclopentolate Sales by Application (2016-2026)
9.3 Asia-Pacific Cyclopentolate Market Size by Region
9.3.1 Asia-Pacific Cyclopentolate Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Cyclopentolate Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Cyclopentolate Sales by Type (2016-2026)
10.2 South America Cyclopentolate Sales by Application (2016-2026)
10.3 South America Cyclopentolate Market Size by Country
10.3.1 South America Cyclopentolate Sales in Volume by Country (2016-2026)
10.3.2 South America Cyclopentolate Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Cyclopentolate Sales by Type (2016-2026)
11.2 Middle East & Africa Cyclopentolate Sales by Application (2016-2026)
11.3 Middle East & Africa Cyclopentolate Market Size by Country
11.3.1 Middle East & Africa Cyclopentolate Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Cyclopentolate Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Cyclopentolate Typical Distributors
12.3 Cyclopentolate Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Cyclopentolate Revenue by Type, (USD Million), 2021-2026
Table 2. Global Cyclopentolate Revenue by Application, (USD Million), 2021-2026
Table 3. Alcon Basic Information, Manufacturing Base and Competitors
Table 4. Alcon Major Business
Table 5. Alcon Cyclopentolate Product and Services
Table 6. Alcon Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Cyclopentolate Product and Services
Table 10. Novartis Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Laboratório Edol Basic Information, Manufacturing Base and Competitors
Table 12. Laboratório Edol Major Business
Table 13. Laboratório Edol Cyclopentolate Product and Services
Table 14. Laboratório Edol Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 16. Cadila Healthcare Major Business
Table 17. Cadila Healthcare Cyclopentolate Product and Services
Table 18. Cadila Healthcare Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. FDC Basic Information, Manufacturing Base and Competitors
Table 20. FDC Major Business
Table 21. FDC Cyclopentolate Product and Services
Table 22. FDC Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dr. Gerhard Mann Basic Information, Manufacturing Base and Competitors
Table 24. Dr. Gerhard Mann Major Business
Table 25. Dr. Gerhard Mann Cyclopentolate Product and Services
Table 26. Dr. Gerhard Mann Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Abdi Ibrahim Basic Information, Manufacturing Base and Competitors
Table 28. Abdi Ibrahim Major Business
Table 29. Abdi Ibrahim Cyclopentolate Product and Services
Table 30. Abdi Ibrahim Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Laboratorios Sophia Basic Information, Manufacturing Base and Competitors
Table 32. Laboratorios Sophia Major Business
Table 33. Laboratorios Sophia Cyclopentolate Product and Services
Table 34. Laboratorios Sophia Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Bausch and Lomb Basic Information, Manufacturing Base and Competitors
Table 36. Bausch and Lomb Major Business
Table 37. Bausch and Lomb Cyclopentolate Product and Services
Table 38. Bausch and Lomb Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Santen Basic Information, Manufacturing Base and Competitors
Table 40. Santen Major Business
Table 41. Santen Cyclopentolate Product and Services
Table 42. Santen Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Riemser Arzneimittel Basic Information, Manufacturing Base and Competitors
Table 44. Riemser Arzneimittel Major Business
Table 45. Riemser Arzneimittel Cyclopentolate Product and Services
Table 46. Riemser Arzneimittel Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Teva Basic Information, Manufacturing Base and Competitors
Table 48. Teva Major Business
Table 49. Teva Cyclopentolate Product and Services
Table 50. Teva Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Akorn Basic Information, Manufacturing Base and Competitors
Table 52. Akorn Major Business
Table 53. Akorn Cyclopentolate Product and Services
Table 54. Akorn Cyclopentolate Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Cyclopentolate Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Cyclopentolate Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Cyclopentolate, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Cyclopentolate Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Cyclopentolate Production Site of Key Manufacturer
Table 60. Cyclopentolate New Entrant and Capacity Expansion Plans
Table 61. Cyclopentolate Mergers & Acquisitions in the Past Five Years
Table 62. Global Cyclopentolate Sales by Region (2016-2021e) & (K Units)
Table 63. Global Cyclopentolate Sales by Region (2021-2026) & (K Units)
Table 64. Global Cyclopentolate Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Cyclopentolate Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Cyclopentolate Sales by Type (2016-2021e) & (K Units)
Table 67. Global Cyclopentolate Sales by Type (2021-2026) & (K Units)
Table 68. Global Cyclopentolate Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Cyclopentolate Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Cyclopentolate Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Cyclopentolate Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Cyclopentolate Sales by Application (2016-2021e) & (K Units)
Table 73. Global Cyclopentolate Sales by Application (2021-2026) & (K Units)
Table 74. Global Cyclopentolate Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Cyclopentolate Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Cyclopentolate Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Cyclopentolate Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Cyclopentolate Sales by Country (2016-2021e) & (K Units)
Table 79. North America Cyclopentolate Sales by Country (2021-2026) & (K Units)
Table 80. North America Cyclopentolate Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Cyclopentolate Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Cyclopentolate Sales by Type (2016-2021e) & (K Units)
Table 83. North America Cyclopentolate Sales by Type (2021-2026) & (K Units)
Table 84. North America Cyclopentolate Sales by Application (2016-2021e) & (K Units)
Table 85. North America Cyclopentolate Sales by Application (2021-2026) & (K Units)
Table 86. Europe Cyclopentolate Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Cyclopentolate Sales by Country (2021-2026) & (K Units)
Table 88. Europe Cyclopentolate Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Cyclopentolate Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Cyclopentolate Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Cyclopentolate Sales by Type (2021-2026) & (K Units)
Table 92. Europe Cyclopentolate Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Cyclopentolate Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Cyclopentolate Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Cyclopentolate Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Cyclopentolate Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Cyclopentolate Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Cyclopentolate Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Cyclopentolate Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Cyclopentolate Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Cyclopentolate Sales by Application (2021-2026) & (K Units)
Table 102. South America Cyclopentolate Sales by Country (2016-2021e) & (K Units)
Table 103. South America Cyclopentolate Sales by Country (2021-2026) & (K Units)
Table 104. South America Cyclopentolate Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Cyclopentolate Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Cyclopentolate Sales by Type (2016-2021e) & (K Units)
Table 107. South America Cyclopentolate Sales by Type (2021-2026) & (K Units)
Table 108. South America Cyclopentolate Sales by Application (2016-2021e) & (K Units)
Table 109. South America Cyclopentolate Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Cyclopentolate Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Cyclopentolate Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Cyclopentolate Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Cyclopentolate Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Cyclopentolate Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Cyclopentolate Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Cyclopentolate Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Cyclopentolate Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Cyclopentolate Typical Distributors
Table 121. Cyclopentolate Typical Customers
List of Figures
Figure 1. Cyclopentolate Picture
Figure 2. Global Cyclopentolate Sales Market Share by Type in 2020
Figure 3. Patent
Figure 4. Generic
Figure 5. Global Cyclopentolate Sales Market Share by Application in 2020
Figure 6. Mydriatic Agent
Figure 7. Muscarinic Receptor Antagonist
Figure 8. Global Cyclopentolate Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Cyclopentolate Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Cyclopentolate Sales (2016-2026) & (K Units)
Figure 11. Global Cyclopentolate Price by Type (2016-2026) & (US$/Unit)
Figure 12. Global Cyclopentolate Production Capacity (2016-2026) & (K Units)
Figure 13. Global Cyclopentolate Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Cyclopentolate Market Drivers
Figure 15. Cyclopentolate Market Restraints
Figure 16. Cyclopentolate Market Trends
Figure 17. Global Cyclopentolate Sales Market Share by Manufacturer in 2020
Figure 18. Global Cyclopentolate Revenue Market Share by Manufacturer in 2020
Figure 19. Cyclopentolate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Cyclopentolate Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Cyclopentolate Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Cyclopentolate Sales Market Share by Region (2016-2026)
Figure 23. Global Cyclopentolate Revenue Market Share by Region (2016-2026)
Figure 24. North America Cyclopentolate Revenue (2016-2026) & (USD Million)
Figure 25. Europe Cyclopentolate Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Cyclopentolate Revenue (2016-2026) & (USD Million)
Figure 27. South America Cyclopentolate Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Cyclopentolate Revenue (2016-2026) & (USD Million)
Figure 29. Global Cyclopentolate Sales Market Share by Type (2016-2026)
Figure 30. Global Cyclopentolate Revenue Market Share by Type (2016-2026)
Figure 31. Global Cyclopentolate Price by Type (2016-2026) & (US$/Unit)
Figure 32. Global Cyclopentolate Sales Market Share by Application (2016-2026)
Figure 33. Global Cyclopentolate Revenue Market Share by Application (2016-2026)
Figure 34. Global Cyclopentolate Price by Application (2016-2026) & (US$/Unit)
Figure 35. North America Cyclopentolate Sales Market Share by Type (2016-2026)
Figure 36. North America Cyclopentolate Sales Market Share by Application (2016-2026)
Figure 37. North America Cyclopentolate Sales Market Share by Country (2016-2026)
Figure 38. North America Cyclopentolate Revenue Market Share by Country (2016-2026)
Figure 39. United States Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Cyclopentolate Sales Market Share by Type (2016-2026)
Figure 43. Europe Cyclopentolate Sales Market Share by Application (2016-2026)
Figure 44. Europe Cyclopentolate Sales Market Share by Country (2016-2026)
Figure 45. Europe Cyclopentolate Revenue Market Share by Country (2016-2026)
Figure 46. Germany Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Cyclopentolate Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Cyclopentolate Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Cyclopentolate Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Cyclopentolate Revenue Market Share by Region (2016-2026)
Figure 55. China Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Cyclopentolate Sales Market Share by Type (2016-2026)
Figure 62. South America Cyclopentolate Sales Market Share by Application (2016-2026)
Figure 63. South America Cyclopentolate Sales Market Share by Country (2016-2026)
Figure 64. South America Cyclopentolate Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Cyclopentolate Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Cyclopentolate Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Cyclopentolate Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Cyclopentolate Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Cyclopentolate Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
制吐薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 An antiemetic drug is a drug that is effective against vomiting and nausea. Antiemetics are typically used to treat motion sickness and the side effects of opioid analgesics, general anaesthetics, antipsychotic medication and chemotherapy directed against cancer. Scope of the Report: This report foc…- 散瞳点眼薬の世界市場2018-2025 In 2018, the global Mydriatic Eyedrops market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Mydriatic Eyedrops. This study re…
- 世界の散瞳眼底カメラ市場 2021：企業別、地域別、種類・用途別 The Mydriatic Fundus Cameras market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 世界の特許医薬品市場 2021：企業別、地域別、種類・用途別 The Patent Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…
- 特許医学の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Today many drug companies which have produced drugs with which the public is very familiar, like Plavix®, Lipitor® and Abilify® Scope of the Report: This report focuses on the Patent Medicine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Afri…